Candid Therapeutics
Clinical trials sponsored by Candid Therapeutics, explained in plain language.
-
New hope for arthritis sufferers? early trial of CND261 begins
Disease control OngoingThis early-stage study tests a new drug called CND261 in 47 adults with moderate to severe rheumatoid arthritis who haven't responded well to other treatments. The main goal is to check the drug's safety and how the body handles it. Researchers will also look for signs that it mi…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
Healthy volunteers needed to test drug absorption
Knowledge-focused OngoingThis study looks at how a new drug called cizutamig enters the bloodstream when given as a shot or under the skin. It involves 24 healthy adults aged 18 to 65. The goal is to measure the drug's bioavailability, not to treat any disease.
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 02:53 UTC